- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-1-mer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.4: 1 residues within 4Å:- Chain A: N.1375
No protein-ligand interaction detected (PLIP)NAG.24: 4 residues within 4Å:- Chain B: V.91, N.93, R.96, F.107
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:R.96
NAG.25: 3 residues within 4Å:- Chain B: G.33, R.89, N.110
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:G.33, B:R.89
NAG.26: 3 residues within 4Å:- Chain B: R.89, T.112, N.114
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:N.114
- 2 x LQO: lacosamide(Non-covalent)
LQO.5: 13 residues within 4Å:- Chain A: T.359, Q.360, I.394, K.1406, T.1695, T.1696, S.1697, A.1698, I.1744, S.1747, F.1748, V.1751, V.1752
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:A.1698, A:V.1751
- Hydrogen bonds: A:K.1406, A:T.1696, A:T.1696
LQO.6: 5 residues within 4Å:- Chain A: A.402, E.406, L.967, L.968, L.1760
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:A.402, A:L.967, A:L.968, A:L.1760
- Hydrogen bonds: A:E.406
- 2 x P5S: O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine(Non-covalent)
P5S.7: 12 residues within 4Å:- Chain A: W.1178, W.1179, R.1182, Y.1186, W.1245, I.1246, A.1247, Y.1248, G.1249, Y.1250, K.1251
- Ligands: LPE.21
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:W.1178, A:I.1246, A:Y.1250, A:Y.1250
- Salt bridges: A:R.1182, A:R.1182, A:K.1251
P5S.14: 13 residues within 4Å:- Chain A: F.254, C.255, L.1488, G.1489, G.1577, W.1578, F.1581, R.1631, L.1634, F.1635, L.1637, M.1638
- Ligands: PCW.15
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:F.254, A:W.1578, A:W.1578, A:W.1578, A:F.1581, A:L.1634, A:L.1634, A:L.1637, A:M.1638
- Salt bridges: A:R.1631
- 4 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
Y01.8: 5 residues within 4Å:- Chain A: F.1254, T.1255, N.1256, A.1257, W.1260
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:W.1260, A:W.1260
Y01.9: 10 residues within 4Å:- Chain A: V.755, T.758, L.759, V.842, S.848, W.849, P.850, L.1326, I.1330, L.1333
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:V.755, A:T.758, A:L.759, A:V.842, A:W.849, A:P.850, A:I.1330, A:L.1333
Y01.10: 9 residues within 4Å:- Chain A: V.833, F.837, M.1338, Y.1429, S.1430, Y.1432, M.1433, I.1435, Y.1436
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:V.833, A:V.833, A:Y.1432, A:I.1435, A:Y.1436
Y01.23: 11 residues within 4Å:- Chain A: L.759, A.762, H.765, P.767, L.1329, I.1330, L.1333, N.1391, V.1392, G.1393, Y.1396
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:L.759, A:A.762, A:P.767, A:L.1329, A:I.1330, A:L.1333, A:V.1392
- Hydrogen bonds: A:N.1391
- Salt bridges: A:H.765, A:H.765
- 8 x LPE: 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
LPE.11: 7 residues within 4Å:- Chain A: P.1733, S.1734, I.1737, F.1738, V.1741, S.1742, I.1745
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:I.1737, A:F.1738, A:V.1741, A:I.1745, A:I.1745
LPE.12: 5 residues within 4Å:- Chain A: A.1257, W.1258, V.1311, N.1312, I.1315
No protein-ligand interaction detected (PLIP)LPE.16: 7 residues within 4Å:- Chain A: E.1477, Q.1478, Y.1481, L.1641, P.1642, L.1644, F.1645
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:L.1641, A:F.1645
- Hydrogen bonds: A:Q.1478
- Salt bridges: A:E.1477
LPE.17: 4 residues within 4Å:- Chain A: Y.1481, A.1484, M.1485
- Ligands: PCW.15
No protein-ligand interaction detected (PLIP)LPE.18: 7 residues within 4Å:- Chain A: D.320, K.376, T.377, M.379, M.1655, G.1685
- Ligands: LPE.19
No protein-ligand interaction detected (PLIP)LPE.19: 10 residues within 4Å:- Chain A: S.1206, G.1207, A.1210, F.1211, M.1307, L.1649, L.1653, F.1656, F.1684
- Ligands: LPE.18
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:L.1649, A:L.1653, A:F.1656
- Hydrogen bonds: A:A.1210
LPE.20: 5 residues within 4Å:- Chain A: V.253, S.257, M.1529, M.1533, A.1627
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:V.253
LPE.21: 6 residues within 4Å:- Chain A: W.1178, W.1179, R.1182, W.1245, Y.1250
- Ligands: P5S.7
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:W.1245
- Hydrogen bonds: A:R.1182
- 3 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
PCW.13: 11 residues within 4Å:- Chain A: Y.339, G.340, Y.341, S.348, W.349, F.351, Q.941, A.942, L.945, M.949, M.950
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:W.349, A:F.351, A:A.942, A:L.945, A:L.945, A:M.949
- Hydrogen bonds: A:Q.941
PCW.15: 14 residues within 4Å:- Chain A: L.1488, K.1491, Q.1494, T.1575, V.1576, G.1577, F.1581, V.1584, I.1588, L.1614, G.1618, M.1638
- Ligands: P5S.14, LPE.17
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:F.1581, A:V.1584
- Hydrogen bonds: A:G.1577
- Salt bridges: A:K.1491
PCW.22: 5 residues within 4Å:- Chain A: F.1574, I.1580, V.1584, I.1587, I.1588
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:F.1574, A:I.1580, A:I.1580, A:V.1584, A:I.1587
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wu, Q. et al., Structural mapping of Na v 1.7 antagonists. Nat Commun (2023)
- Release Date
- 2023-08-30
- Peptides
- Sodium channel protein type 9 subunit alpha: A
Sodium channel subunit beta-1: B
Sodium channel subunit beta-2: C - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-1-mer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x LQO: lacosamide(Non-covalent)
- 2 x P5S: O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine(Non-covalent)
- 4 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 8 x LPE: 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- 3 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wu, Q. et al., Structural mapping of Na v 1.7 antagonists. Nat Commun (2023)
- Release Date
- 2023-08-30
- Peptides
- Sodium channel protein type 9 subunit alpha: A
Sodium channel subunit beta-1: B
Sodium channel subunit beta-2: C - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C - Membrane
-
We predict this structure to be a membrane protein.